Erasmus Orders 250 Genomes from Complete Genomics to Study Cancer, Congenital Malformations
May 24, 2011
Erasmus Orders 250 Genomes from Complete Genomics to Study Cancer, Congenital Malformations
The order, which expands the medical center's collaboration with the company, is part of an Erasmus-led research study seeking to improve the diagnosis and treatment of patients with diseases whose genetic origins have been difficult to discern.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Complete Genomics Expects CLIA Certification This Year, Long Fragment Read Tech by 2013
May 9, 2012 / Clinical Sequencing News - Complete Genomics Partners with Scripps to Sequence 1K Genomes of the Healthy Elderly for Free
October 5, 2011 / Clinical Sequencing News - Complete Genomics Says Human Sequencing Shifting from Research to Clinical Market
September 21, 2011 / Clinical Sequencing News - Inova Says Complete Genomics Deal is Step Toward Broad Adoption of Sequencing in Healthcare System
September 14, 2011 / Clinical Sequencing News - People in the News
August 31, 2011 / Clinical Sequencing News